Search Results

You are looking at 41 - 50 of 189 items for :

  • arteriosclerosis x
  • User-accessible content x
Clear All
Free access

Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Masashi Akaike, and Toshio Matsumoto

artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness . Arteriosclerosis, Thrombosis, and Vascular Biology 15 562 – 570 . doi:10.1161/01.ATV.15.5.562 . Akishita M Hashimoto M Ohike Y Ogawa S Iijima K Eto

Free access

Mohamed Asrih and François R Jornayvaz

dysfunction in obese subjects . Arteriosclerosis, Thrombosis, and Vascular Biology 28 1654 – 1659 . ( doi:10.1161/ATVBAHA.108.170316 ) Arita Y Kihara S Ouchi N Takahashi M Maeda K Miyagawa J Hotta K Shimomura I Nakamura T Miyaoka K

Free access

Karen Oliva, Gillian Barker, Gregory E Rice, Mark J Bailey, and Martha Lappas

attenuates vascular inflammation and remodeling and improves endothelial function in mice . Arteriosclerosis, Thrombosis, and Vascular Biology 31 95 – 101 . ( doi:10.1161/ATVBAHA.110.216747 ) Fisher AB 2011 Peroxiredoxin 6: a bifunctional enzyme

Free access

Ji-Eun Kim, Seung Eun Song, Yong-Woon Kim, Jong-Yeon Kim, Sung-Chul Park, Yoon-Ki Park, Suk-Hwan Baek, In Kyu Lee, and So-Young Park

against angiotensin II-induced cardiac fibrosis through activation of PPAR-α . Arteriosclerosis, Thrombosis, and Vascular Biology 28 863 – 870 doi:10.1161/ATVBAHA.107.156687 . Fulda S Debatin KM 2006 Resveratrol modulation of signal

Free access

Pongpan Tanajak, Siriporn C Chattipakorn, and Nipon Chattipakorn

sensitivity ↓ Apoptosis, MI ↑ FGFR1/β-Klotho–PI3K–Akt1–BAD signaling ApoE −/− mice Abdominal aortic (AA) arteriosclerosis for 4 weeks FGF21 100 μg/kg per day, s.c. injection for 4 weeks ↑ AA luminar diameter FGF21

Restricted access

Hui-Fang Wang, Qing-Qing Yu, Rui-Fang Zheng, and Ming Xu

expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling . Arteriosclerosis, Thrombosis, and Vascular Biology 1704 – 1715 . ( https://doi.org/10.1161/ATVBAHA.114.303848 ) Brunet I Gordon E Han J Cristofaro B

Free access

Irene Andrés-Blasco, Andrea Herrero-Cervera, Ángela Vinué, Sergio Martínez-Hervás, Laura Piqueras, María Jesús Sanz, Deborah Jane Burks, and Herminia González-Navarro

signaling . Arteriosclerosis, Thrombosis, and Vascular Biology 28 2187 – 2194 . ( doi:10.1161/ATVBAHA.108.175299 ) Gonzalez-Navarro H Abu Nabah YN Vinue A Andres-Manzano MJ Collado M Serrano M Andres V 2010 p19(ARF) deficiency reduces

Free access

Giselle Adriana Abruzzese, Maria Florencia Heber, Silvana Rocio Ferreira, Leandro Martin Velez, Roxana Reynoso, Omar Pedro Pignataro, and Alicia Beatriz Motta

.2008 ) den Boer M Voshol PJ Kuipers F Havekes LM Romijn JA 2004 Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models . Arteriosclerosis, Thrombosis, and Vascular Biology 24 644 – 649 . ( doi:10

Free access

Hao Wu, Junduo Wu, Shengzhu Zhou, Wenlin Huang, Ying Li, Huan Zhang, Junnan Wang, and Ye Jia

molecule-1 induction by advanced glycation end products . Arteriosclerosis, Thrombosis, and Vascular Biology 25 1401 – 1407 . ( https://doi.org/10.1161/01.ATV.0000167522.48370.5e) 15845907 10.1161/01.ATV.0000167522.48370.5e Brooks CL Gu W 2003

Free access

Timothy J Cole and Morag J Young

. Arteriosclerosis, Thrombosis, and Vascular Biology 34 355 – 364 . ( doi:10.1161/ATVBAHA.113.302854 ) Rafestin-Oblin ME Souque A Bocchi B Pinon G Fagart J Vandewalle A 2003 The severe form of hypertension caused by the activating S